The field of oncology is rapidly growing and evolving. In 2022, global spending on cancer medicines was approximately 196 billion USD and this number is…
As well as exposing companies to non-compliance, inefficiency and delays, a manually-maintained pharmacovigilance system master file (PSMF) limits visibility and transparency. Christian Schmitz-Moormann, a senior…
Adnan Jamil of Deloitte sets out specific recommendations and emerging leading practices as Life Sciences organisations assess what’s needed from next-generation regulatory information management (RIM)…
Millions of women worldwide are affected by breast cancer, a prevalent form of cancer. For approximately 8 out of 10 cases, invasive ductal carcinoma (IDC)…
Throughout the 2020s, pharmaceutical companies have been thrust under the spotlight like never before. Fortunately, they’ve largely responded exceptionally, delivering life-saving vaccine treatments at record…
Breakthroughs with immunotherapy and the mRNA platform are heralding a new dawn for cancer treatment. Drs Daina Vanags, Cori Gorman and Christian K Schneider of…
The pharmaceutical industry is expected to grow at a CAGR of 11.34% and reach $486.62 billion by 2028. With such a vast market size and jostling for…
As the Life Sciences sector becomes increasingly data-driven, knowledge graph technology is helping companies uncover connections and insights from multiple data sources. Neo4j’s Alexander Jarasch…
The COVID-19 pandemic turned virtual congresses from a relatively rare occurrence to a must-have in 2020. While we saw some attempts at hybrid and in-person…
As 2022 drew to a close, Amplexor asked some of its closest industry partners and regular event speakers for their views on the most pivotal…
